Submitted by Anonymous (not verified) on 28 January 2026 - 16:26
Human medicines European public assessment report (EPAR): Heplisav B, hepatitis B surface antigen, Date of authorisation: 18/02/2021, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Heplisav B, hepatitis B surface antigen, Date of authorisation: 18/02/2021, Revision: 8, Status: Authorised